Evaluation of an Oat Fiber Supplement on Health
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorCalifornia Polytechnic State University-San Luis Obispo
About this trial
The purpose of the study is to determine whether short-term use of an oat fiber supplement reduces exposure to your urine levels of dietary chemicals like bisphenol A (BPA).
This study will also examine whether supplementation with NeutraOat oat fiber influences blood glucose levels using continuous glucose monitoring.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Participants will be healthy
Weight-stable for the previous 6 months
Free of any metabolic or chronic disease
Non-smoking (to include vaping and other nicotine or THC containing products)
Disqualifiers
Any chronic or metabolic disease, including type 1 or type 2 diabetes
Gastrointestinal (GI) diseases/disorders
Neurologic or psychiatric conditions
Nicotine or THC consumption
Trial design
Design model
Crossover
Treatments tested in this trial
Oat Fiber
Dietary supplement4 grams of supplementation by capsule per day for two days
Placebo
Dietary supplement4 grams of supplementation (placebo) by capsule per day for two days
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: Oat Fiber SupplementExperimental treatment 1 intervention
Group B: PlaceboPlacebo comparator 1 intervention
Trial outcomes
Primary outcomes
1
Urine Plasticizer Concentration
Plasticizer concentration in urine samples measured before and after oat fiber supplementation.
Time frame
Urine samples will be take over the course of three weeks.Secondary outcomes
1
Blood Glucose Levels
Blood glucose levels before and after supplementation with oat fiber.
Time frame
Blood glucose levels will be monitored over the course of 3 weeks.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: